Cargando…

CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most prevalent malignant tumor in head and neck region. Platinum drug resistance limits the clinical application of chemotherapy regardless of medical development. The aim of our study is to identify cisplatin-resistant genes which can be used a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Xue, Zhu, Li, Song, Rongbo, Shang, Chao, Guo, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982036/ https://www.ncbi.nlm.nih.gov/pubmed/36827716 http://dx.doi.org/10.1016/j.tranon.2023.101644

Ejemplares similares

Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma
por: Zargaran, Massoumeh
Publicado: (2020)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
por: Gotley, D. C., et al.
Publicado: (1996)

Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts
por: Hernandez, James R., et al.
Publicado: (2015)

Emerging roles of alternative RNA splicing in oral squamous cell carcinoma
por: Liu, Miaomiao, et al.
Publicado: (2022)

hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing
por: Peng, Wei-zhao, et al.
Publicado: (2019)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2020)

Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer
por: Qiao, Xue, et al.
Publicado: (2021)

Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma.
por: Kim, Y. S., et al.
Publicado: (1997)

Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression
por: Bánky, Balázs, et al.
Publicado: (2012)

CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma
por: Shakib, Pouyan Amini, et al.
Publicado: (2015)

CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation
por: Zhang, Pu, et al.
Publicado: (2016)

Utility of CD44/CD24 in the Outcome and Prognosis of Oral Squamous Cell Carcinoma: A Systematic Review
por: Poothakulath Krishnan, Reshma, et al.
Publicado: (2023)

The landscape of alternative splicing in cervical squamous cell carcinoma
por: Guo, Peng, et al.
Publicado: (2014)

Cisplatin-Resistant CD44(+) Lung Cancer Cells Are Sensitive to Auger Electrons
por: Madsen, Karina Lindbøg, et al.
Publicado: (2022)

CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms
por: Batsché, Eric, et al.
Publicado: (2021)

Identification of CD44 splice variant in Korean colorectal cancers and cell lines.
por: Suh, S. I., et al.
Publicado: (1995)

Immunohistochemical study of CD44s expression in oral squamous cell carcinoma-its correlation with prognostic parameters
por: Hema, KN, et al.
Publicado: (2014)

The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma
por: Irani, Soussan, et al.
Publicado: (2018)

PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells
por: Zhang, Tong, et al.
Publicado: (2010)

CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field
por: Su, Zhan, et al.
Publicado: (2019)

CD44v3(+)/CD24(−) cells possess cancer stem cell-like properties in human oral squamous cell carcinoma
por: TODOROKI, KEITA, et al.
Publicado: (2015)

Development of alternative splicing signature in lung squamous cell carcinoma
por: Yan, Jia-qing, et al.
Publicado: (2021)

Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon
Publicado: (1995)

Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations
por: Svobodova, Marketa, et al.
Publicado: (2017)

CD44 splice isoform switching determines breast cancer stem cell state
por: Zhang, Honghong, et al.
Publicado: (2019)

CD44 Mediates Oral Squamous Cell Carcinoma-Promoting Activity of MRE11 via AKT Signaling
por: Yuan, Shyng-Shiou F., et al.
Publicado: (2022)

Molecular biomarkers NOTCH1, CD44, BMI1, and TP53 in oral squamous cell carcinoma
por: Reshma, Mohammad, et al.
Publicado: (2023)

The Differential Metabolic Response of Oral Squamous Cell Carcinoma Cells and Normal Oral Epithelial Cells to Cisplatin Exposure
por: Chen, Xun, et al.
Publicado: (2022)

DASES: a database of alternative splicing for esophageal squamous cell carcinoma
por: Chen, Yilong, et al.
Publicado: (2023)

Dendritic cells loaded with CD44(+) CT-26 colon cell lysate evoke potent antitumor immune responses
por: Fu, Changhao, et al.
Publicado: (2019)

Evaluation of CD24 and CD44 as cancer stem cell markers in squamous cell carcinoma and epithelial dysplasia of the oral cavity by q- RT-PCR
por: Mirhashemi, Majid, et al.
Publicado: (2020)

Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Li, Long, et al.
Publicado: (2016)

WNT5A Inhibits Metastasis and Alters Splicing of Cd44 in Breast Cancer Cells
por: Jiang, Wen, et al.
Publicado: (2013)

SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells
por: Wang, Cheng, et al.
Publicado: (2020)

A network of conserved co-occurring motifs for the regulation of alternative splicing
por: Suyama, Mikita, et al.
Publicado: (2010)

Characterization of CD44 variant expression in head and neck squamous cell carcinomas
por: Spiegelberg, D., et al.
Publicado: (2013)

Expression of CD44 in Head and Neck Squamous Cell Carcinoma—An In-Silico Study
por: Kavitha, Loganathan, et al.
Publicado: (2023)

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_okv72fta6s22b1olhnrep79ggu